Euglena gracilis paramylon activates human lymphocytes by upregulating pro-inflammatory factors

被引:72
作者
Russo, Rossella [1 ]
Barsanti, Laura [2 ]
Evangelista, Valter [2 ]
Frassanito, Anna M. [2 ]
Longo, Vincenzo [1 ]
Pucci, Laura [1 ]
Penno, Giuseppe [3 ]
Gualtieri, Paolo [2 ]
机构
[1] CNR, Ist Biol & Biotecnol Agr, Pisa, Italy
[2] CNR, Ist Biofis, Via Moruzzi 1, I-56124 Pisa, Italy
[3] Univ Pisa, Dipartimento Med Clin & Sperimentale, Sez Malattie Metab, Pisa, Italy
关键词
Euglena; glucans; innate immunity; MacroGard (R); paramylon;
D O I
10.1002/fsn3.383
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The aim of this study was to verify the activation details and products of human lymphomonocytes, stimulated by different beta-glucans, that is Euglena paramylon, MacroGard (R), and lipopolysaccharide. We investigated the gene expression of inflammation-related cytokines and mediators, transactivation of relevant transcription factors, and phagocytosis role in cell-glucan interactions, by means of RT-PCR, immunocytochemistry, and colorimetric assay. Our results show that sonicated and alkalized paramylon upregulates pro-inflammatory factors (NO, TNF-alpha, IL-6, and COX-2) in lymphomonocytes. A clear demonstration of this upregulation is the increased transactivation of NF-kB visualized by immunofluorescence microscopy. Phagocytosis assay showed that internalization is not a mandatory step for signaling cascade to be triggered, since immune activity is not present in the lymphomonocytes that have internalized paramylon granules and particulate MacroGard (R). Moreover, the response of Euglena beta-glucan-activated lymphomonocytes is much greater than that induced by commercially used beta-glucans such as MacroGard (R). Our in vitro results indicate that linear fibrous Euglena beta-glucan, obtained by sonication and alkaline treatment can act as safe and effective coadjutant of the innate immune system response.
引用
收藏
页码:205 / 214
页数:10
相关论文
共 45 条
[1]  
Alaban Leovigildo R.S., 2014, ABAH Bioflux, V6, P168
[2]  
Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1177/09680519010070030101
[3]   β-Glucan-Activated Human B Lymphocytes Participate in Innate Immune Responses by Releasing Proinflammatory Cytokines and Stimulating Neutrophil Chemotaxis [J].
Ali, Mohamed F. ;
Driscoll, Christopher B. ;
Walters, Paula R. ;
Limper, Andrew H. ;
Carmona, Eva M. .
JOURNAL OF IMMUNOLOGY, 2015, 195 (11) :5318-5326
[4]   Cell type-specific differences in β-glucan recognition and signalling in porcine innate immune cells [J].
Baert, Kim ;
Sonck, Eva ;
Goddeeris, Bruno M. ;
Devriendt, Bert ;
Cox, Eric .
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2015, 48 (01) :192-203
[5]   Paramylon (β-1,3-glucan) content in wild type and WZSL mutant of Euglena gracilis.: Effects of growth conditions [J].
Barsanti, L ;
Vismara, R ;
Passarelli, V ;
Gualtieri, P .
JOURNAL OF APPLIED PHYCOLOGY, 2001, 13 (01) :59-65
[6]   Chemistry, physico-chemistry and applications linked to biological activities of β-glucans [J].
Barsanti, Laura ;
Passarelli, Vincenzo ;
Evangelista, Valtere ;
Frassanito, Anna Maria ;
Gualtieri, Paolo .
NATURAL PRODUCT REPORTS, 2011, 28 (03) :457-466
[7]   The effects of β-glucan on human immune and cancer cells [J].
Chan, Godfrey Chi-Fung ;
Chan, Wing Keung ;
Sze, Daniel Man-Yuen .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2009, 2
[8]   Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post-translational modification of IκB [J].
Chang, K ;
Lee, SJ ;
Cheong, I ;
Billiar, TR ;
Chung, HT ;
Han, JA ;
Kwon, YG ;
Ha, KS ;
Kim, YM .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2004, 36 (04) :311-324
[9]   PACKING ANALYSIS OF CARBOHYDRATES AND POLYSACCHARIDES .13. TRIPLE-HELICAL STRUCTURE OF (1-]3)-BETA-D-GLUCAN [J].
DESLANDES, Y ;
MARCHESSAULT, RH ;
SARKO, A .
MACROMOLECULES, 1980, 13 (06) :1466-1471
[10]   Rational Design of Adjuvant for Skin Delivery: Conjugation of Synthetic β-Glucan Dectin-1 Agonist to Protein Antigen [J].
Donadei, Agnese ;
Gallorini, Simona ;
Berti, Francesco ;
O'Hagan, Derek T. ;
Adamo, Roberto ;
Baudner, Barbara C. .
MOLECULAR PHARMACEUTICS, 2015, 12 (05) :1662-1672